1228168

3D Imaging Drug Design and Development LLC — FEI 3009143510

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Little Rock, AR (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures